Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Camden Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Camden Asset Management
from 13F filings
Historical chart of Camden Asset Management investment in Halozyme Therapeutics Inc Note 1.000 8/1
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Camden Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Camden Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $12B | 13M | 933.75 |
Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1
View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1